Literature DB >> 31296641

Autoimmune hepatitis following Epstein-Barr virus infection: a diagnostic dilemma.

Haoran Peng1, Tanna Lim1, Jae Nam1, Jin Lee1.   

Abstract

Epstein-Barr virus (EBV) infections frequently affect the liver and cause hepatitis. EBV is a well-known trigger of certain autoimmune diseases. There are few case reports showing the evidence of autoimmune hepatitis (AIH) following EBV infection. However, the diagnosis of AIH is very challenging in the setting of an acute infection. Here, we demonstrate a case of AIH following EBV infection in a patient ultimately recovered after receiving treatment for AIH. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  gastrointestinal system; liver disease

Mesh：

Substances：

Year:  2019        PMID： 31296641      PMCID： PMC6626455          DOI： 10.1136/bcr-2019-229615

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  6 in total

1.  Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

2.  Possible autoimmune hepatitis induced after chronic active Epstein-Barr virus infection.

Authors:  Yoshiko Wada; Chikako Sato; Kyoko Tomita; Rika Ishii-Aso; Hiroaki Haga; Kazuo Okumoto; Yuko Nishise; Hisayoshi Watanabe; Takafumi Saito; Yoshiyuki Ueno
Journal:  Clin J Gastroenterol       Date:  2013-11-23

3.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

4.  Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals.

Authors:  S Vento; L Guella; F Mirandola; F Cainelli; G Di Perri; M Solbiati; T Ferraro; E Concia
Journal:  Lancet       Date:  1995-09-02       Impact factor: 79.321

5.  Autoimmune hepatitis type-2 and Epstein-Barr virus infection in a toddler: art of facts or an artifact?

Authors:  Aglaia Zellos; Vana Spoulou; Eleftheria Roma-Giannikou; Ourania Karentzou; George N Dalekos; Maria Theodoridou
Journal:  Ann Hepatol       Date:  2013 Jan-Feb       Impact factor: 2.400

6.  Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.

Authors:  Carmen Cuffari; Themistocles Dassopoulos; Lisa Turnbough; Richard E Thompson; Theodore M Bayless
Journal:  Clin Gastroenterol Hepatol       Date:  2004-05       Impact factor: 11.382
  6 in total
  1 in total

1.  Chronic Active Epstein-Barr Virus Infection Indistinguishable from Autoimmune Hepatitis: A Case Report.

Authors:  Suguru Ikeda; Takaaki Sugihara; Takuya Kihara; Yoshiki Hoshino; Yukako Matsuki; Takakazu Nagahara; Kenji Oyama; Jun-Ichi Okano; Satoshi Kuwamoto; Yasushi Horie; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2022-04-13       Impact factor: 1.371
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.